December IPO profiles: Drug-discovery company Moderna leads the way


IPO Guest Column VCJ Venture
Photo of IPO with trading data in the background courtesy of designer491/iStock/Getty Images.
IPO activity ended on a strong note in the year with three new VC-backed debuts in December, compared with just one new venture-backed public offering the month before. Combined proceeds in December from the three new issues rose nearly 14 ...

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.